Pharmaceuticals

Pharmacogenetic Testing Market Forecast Highlighting Key Trends And Expansion Potential

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Pharmacogenetic Testing Market Expected To Scale Between 2026 And 2030?

The pharmacogenetic testing market has experienced significant expansion recently. Its size is expected to increase from $14.33 billion in 2025 to $16.58 billion in 2026, registering a compound annual growth rate (CAGR) of 15.7%. Historically, this growth has been driven by progress in genomic sequencing technologies, concerns about adverse drug reactions, the escalating burden of chronic diseases, falling genetic testing costs, and greater clinical awareness.

The pharmacogenetic testing market size is expected to experience significant expansion in the next few years. It is projected to reach $29.55 billion in 2030, with a compound annual growth rate (CAGR) of 15.5%. The expansion during the forecast period is largely attributable to the advancement of precision healthcare, the widening scope of direct-to-consumer testing, better integration with electronic health records, enhanced regulatory backing, and increasing investment in genomics research. Key trends anticipated in the forecast period include the rising acceptance of personalized medicine, a greater utilization of genetic testing for drug selection, the broadening of oncology and cardiology applications, an escalating demand for precision diagnostics, and the integration of pharmacogenomics into routine clinical practice.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp

What Key Drivers Are Fueling The Growth Of The Pharmacogenetic Testing Market?

The escalating need for personalized medicine is projected to propel the expansion of the pharmacogenetic testing market moving forward. Personalized medicine, also referred to as precision medicine, represents a healthcare approach that customizes treatments and medical decisions based on an individual’s distinct genetic, biological, and lifestyle attributes. The impetus for personalized medicine is growing because of its effectiveness in improving treatment results, aiding early diagnosis, and enhancing cost-efficiency in patient care. The pharmacogenetic testing market facilitates personalized medicine by evaluating an individual’s genetic makeup to forecast drug responses, thus enabling optimized treatment choices and lessening the likelihood of adverse reactions. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a rise from 6 approvals in 2022. As a result, the rising demand for personalized medicine is a key factor driving the growth of the pharmacogenetic testing market.

What Segment Categories Shape The Pharmacogenetic Testing Market Segment Landscape?

The pharmacogenetic testing market covered in this report is segmented –

1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests

2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications

3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services

5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users

Subsegments:

1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing

2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing

3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing

4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes

What Emerging Trends Are Seen In The Pharmacogenetic Testing Market?

Leading companies in the pharmacogenetics testing market are concentrating on developing advanced pharmacogenomics testing services, such as prescription-based pharmacogenetic testing, to boost medication safety, improve treatment precision, and support individualized therapeutic decision-making. Prescription-based pharmacogenetic testing refers to genetic analyses ordered by licensed healthcare providers to examine how an individual’s genetic makeup influences their response to specific medications, allowing clinicians to optimize drug selection and dosing while reducing the likelihood of adverse drug reactions. For instance, in May 2023, UCSF, a US-based healthcare organization, launched its pharmacogenomics testing service designed to improve the precision of medical treatments, providing healthcare professionals with genetic insights that help tailor drug therapies to each patient’s unique profile, strengthen drug efficacy, and minimize the risk of harmful side effects.

Who Are The Companies Operating Across The Pharmacogenetic Testing Market Value Chain?

Major companies operating in the pharmacogenetic testing market are CVS Health Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics Incorporated, Eurofins Scientific Inc., Bio-Rad Laboratories, Precision Medicine Advsiors, Azenta Life Sciences, Fulgent Genetics, Pacific Biosciences of California Inc., Castle Biosciences, 23andMe Holding Co., Helix Inc., Genomind Inc., MD Labs, Sonic Genetics, AutoGenomics Inc., LabClinics SA, Gene By Gene Ltd., Xcode Life Sciences, YouScript, RxGenomix LLC

Get The Full Pharmacogenetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Which Region Accounts For The Largest Portion Of The Pharmacogenetic Testing Market?

Asia-Pacific was the largest region in the pharmacogenetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Pharmacogenetic Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report

Browse Through More Reports Similar to the Global Pharmacogenetic Testing Market 2026, By The Business Research Company

Neurogenetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Genetic Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-toxicology-testing-global-market-report

Genetic Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/genetic-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795